year 1, Issue 3 (Fall 2007)                   Iran J Med Microbiol 2007, 1(3): 53-56 | Back to browse issues page

XML Persian Abstract Print


1- Loghman Hakim Hospital, Shaheed Beheshti University of Medical Sciences , zohrehaminzadeh@yahoo.com
2- Loghman Hakim Hospital, Shaheed Beheshti University of Medical Sciences
Abstract:   (12939 Views)
Background and Objectives: Intravenous drug using is a main risk factor for getting infected with HIV, Hepatitis B and C viruses. The syphilis is a common infection. The aim of this study was to investigate the seroepidemiology of HIV, syphilis, hepatitis B and C among the intravenous drug users (IDUs) at Loghman Hakim hospital, Tehran.
Materials & Methods: A descriptive (cross- sectional) study with observative-interview technique was conducted. 70 admitted IDUs patients in LoghmanHakim hospital during July- December 2007 were included in this study. The patients with mean of age 34.4+/- 9.6 and mean of oral drug 66.15+/- 82.5 months, mean of intravenous drug 48.94+/-48.46 months, mean of inhalation drug 87.05+/- 84.14 months were studied.
Results: 74.5% of the patients had been in prison and 11.5% of them shared syringe. The positive results obtained for the serological tests of 70 patients were in the following order: Anti- HCV (36%), Anti-HIV (30%), HBsAb (11.5%) and HBsAg ( 6%). None of the patients was positive in RPR test. There was no significant correlations between the routes of using drug, history in prison and results of serology. Importantly, a significant correlation was found between the sharing syringe and positivity for Anti-HCV by itself or co-infection of HCV with HIV.
Conclusion: HCV is the most common infection among the intravenous drug users followed by HIV and Hepatitis B. A lack of RPR shows infection with syphilis is under control.
Full-Text [PDF 99 kb]   (3418 Downloads)    
Type of Study: Original Research Article | Subject: Medical Virology
Received: 2007/12/13 | Accepted: 2013/11/14 | ePublished: 2013/11/14

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.